Coccidioides immitis spherule
- Generic Name
- Coccidioides immitis spherule
- Brand Names
- Spherusol
- Drug Type
- Biotech
- Unique Ingredient Identifier
- ITY7G7Q744
Overview
Coccidioides immitis spherule is a skin test antigen indicated to detect delayed-type hypersensitivity to Coccidioides immitis in individuals with a history of pulmonary coccidioidomycosis.
Background
Coccidioides immitis spherule is a skin test antigen indicated to detect delayed-type hypersensitivity to Coccidioides immitis in individuals with a history of pulmonary coccidioidomycosis.
Indication
Indicated to detect delayed-type hypersensitivity to Coccidioides immitis in individuals with a history of pulmonary coccidioidomycosis. Use in 18-64 year old patients. A positive result occurs if 48h after administration if the diameter of the induration is >5mm.
Associated Conditions
- Delayed-type hypersensitivity to Coccidioides immitis
Clinical Trials
No clinical trials found for this drug
FDA Approved Products
Spherusol
Manufacturer:Nielsen BioSciences, Inc.
Route:INTRADERMAL
Strength:12.7 ug in 1 mL
Approved: 2022/06/13
NDC:59584-140
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath